Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

432
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
432
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

155
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
155
Dementia01:30

Dementia

92
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
92
Neural Regulation01:37

Neural Regulation

39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phytosynthesis of silver nanoparticles using the leaves extract of Ficus talboti king and evaluation of antioxidant and antibacterial activities.

Environmental science and pollution research international·2015
See all related articles

Related Experiment Video

Updated: May 28, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

941

Alzheimer's Disease detection and classification using optimized neural network.

Nair Bini Balakrishnan1, Anitha S Pillai1, Jisha Jose Panackal2

  • 1Department of Computer Science, Hindustan Institute of Technology and Science, Chennai, India.

Computers in Biology and Medicine
|February 11, 2025
PubMed
Summary

This study introduces a novel Deep Reinforcement Learning with Moth Flame Optimized Recurrent Neural Network (DRL-MFORNN) for Alzheimer's disease (AD) detection. The DRL-MFORNN model achieved high accuracy in identifying AD from brain MRI scans.

Keywords:
Alzheimer's detectionDeep reinforcement learningMoth flame optimizationRecurrent neural network

More Related Videos

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

85
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.8K

Related Experiment Videos

Last Updated: May 28, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

941
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

85
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.8K

Area of Science:

  • Neurology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Alzheimer's disease (AD) is a neurodegenerative disorder causing cognitive decline.
  • Early and accurate AD diagnosis is crucial for effective treatment and improved patient outcomes.

Purpose of the Study:

  • To develop a novel approach for Alzheimer's disease (AD) detection using Deep Reinforcement Learning (DRL) and a Moth Flame Optimized Recurrent Neural Network (MFORNN).
  • To enhance the accuracy and efficiency of AD identification from brain MRI scans.

Main Methods:

  • Brain MRI samples were preprocessed to remove noise and enhance quality.
  • The Moth Flame Optimization (MFO) algorithm was employed for feature selection from MRI images.
  • Recurrent Neural Networks (RNNs) were utilized to learn temporal patterns, with parameters fine-tuned by Deep Reinforcement Learning (DRL).
  • The framework was implemented using Python.

Main Results:

  • The proposed DRL-MFORNN algorithm achieved high performance metrics: 99.31% accuracy, 99.24% precision, 99.43% recall, and 99.35% f-measure.
  • Comparative analysis demonstrated the superior performance of the proposed technique over conventional classification algorithms.

Conclusions:

  • The DRL-MFORNN approach offers a highly accurate and efficient method for Alzheimer's disease detection.
  • This novel framework shows significant potential for clinical application in early AD diagnosis.